FDA clears Sun Pharmaceutical’s generic Prandin diabetes drug
The US regulator approved the company’s abbreviated new drug applications (ANDA) for Repaglinide tablets, 1mg and 2mg, which are therapeutic equivalents of Novo Nordisk’s Prandin tablets. Indicated as
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.